Jul
01
2003

Beware Of Binges

In the June 16, 2003 issue of Time (page 73) an article appeared under the heading “Summertime booze”. A study from the Buffalo University showed that women, in particular, have to be conscious that drinking 3 or 4 drinks at one time on the weekend is not the same as drinking the same 3 to 4 drinks over the course of one week.

A study looking at the frequency of breast cancer in relation to drinking patterns found that the binge drinking women had a 80% higher breast cancer risk than the controls who drank 3 to 4 drinks at a time (but only one drink per day). Jo Freudenheim, the epidemiologist involved in this study, suggested that perhaps with the binge drinking alcohol’s toxic potential for breast cancer cells had been reached whereas with one drink at a time over one week this level was never encountered.

In another study from the Buffalo University liver toxicity as a result of alcohol exposure was examined. These researchers used blood tests to measure liver enzymes, which were leaking from the liver cells as a result of the toxic effect of alcohol. Both men and women were tested and various drinking patterns were also studied. Men who drink several drinks daily had the highest liver enzyme counts (reflecting the toxic effect of alcohol on the liver). However, women who drink only on weekends had even higher counts of the liver enzymes than men! Women who drank on an empty stomach had much higher liver enzymes in these studies than men where this effect did not show (with men it did not matter whether they drank with food or on an empty stomach).

Beware Of Binges

Beware Of Binges

The researchers concluded that binge drinking appears to affect women more than men. Generally speaking the higher the amount of alcohol consumed, the more toxic the effects on body cells and on the liver. Moderation may be in order.

Comments: These type of studies are particularly important in view of the fact of marketing techniques of the wine industry. Wine and alcoholic beverages are being portrayed as being a good source of bioflavonoids that are lowering cholesterol and would prevent or postpone heart attacks. Some of the data on cancer indicates that for ovarian cancer and colorectal cancer there may not be a safe low dose as even one drink per day can have a measurable effect on cancer risk. On the other hand, bioflavonoids are abundantly present in raw vegetables and fruit, so there is no panic about not getting enough heart attack preventing foods. Finally, a bit of common sense does not harm: alcohol is a cell toxin, so it should be diluted (nothing stronger than wine) and if you desire a drink, use it in moderation.

Link to chapter on alcoholism in Net Health Book:

http://nethealthbook.com/drug-addiction/alcoholism/

Last edited October 26, 2014

 

Nov
01
2002

New Blood Test To Predict Breast Cancer Survival Rate

Dr. Keyomarsi, a researcher and radiation oncologist from the M.D. Anderson Cancer Institute in Houston/Texas, has published a very important piece of research in the New England Journal of Medicine (N Engl J Med 2002;347:1546-1547,1566-1575). A group of 394 breast cancer patients were followed for 6.4 years and cyclin E was measured with a special blood test. Cyclin E is a key substance involved in cell division in general and also in breast cancer cells. Dr. Kyomarsi’s research showed that cyclin E, and in particular high levels of its socalled “truncated isoforms”, correlated very well with poor survival. On the other hand low cyclin E levels (truncated isoforms) were a powerful predictor for excellent survival. In the above mentioned breast cancer study 12 patients out of a group of stage 1 patients (= localized breast cancer) died after an average of 4.1 years from the point of diagnosis. All of these patients had high cyclin E levels. In contrast, none of the other stage 1 patients had died within 5 years from the diagnosis and all of their cyclin E levels were low. Other known risk factors for poor survival are lymph gland metastases, negative estrogen receptors on the surface of the cancer cells and late-stage disease. Each of those factors has a risk of about 1.7-fold. A high (truncated isoform) cyclin E level is associated with a 2.1-fold risk when compared to the low risk group with a low cyclin E level. There is a subgroup of breast cancer patients with high total cyclin E levels who have a risk of 13.3-fold of dying from breast cancer.

New Blood Test To Predict Breast Cancer Survival Rate

New Blood Test To Predict Breast Cancer Survival Rate

You may want to read these useful related links to chapters of my free Internet based Nethealthbook: A general overview regarding cancer: http://www.nethealthbook.com/articles/cancer_canceroverview.php#cancer This chapter deals specifically with breast cancer: http://www.nethealthbook.com/articles/cancer_breastcancer.php

Last edited December 10, 2012